Jim Frates

Jim Frates

Director Financiero/CFO en AMYLYX PHARMACEUTICALS, INC. .

Fortuna: 14 M $ al 31/08/2026

58 años
Consumer Services
Commercial Services
Health Technology

Perfil

Mr. James M.
Frates
is a Chief Financial Officer at Amylyx Pharmaceuticals, Inc. He is on the Board of Directors at St. Francis House.
Mr. Frates was previously employed as an Independent Director by SAGE Therapeutics, Inc., a National Director by The Association of Bioscience Financial Officers, a Chief Financial Officer & Senior Vice President by Alkermes Plc, a Vice President-Investment Banking by Robertson Stephens & Co., a Treasurer & Trustee by Roxbury Latin School, and a Treasurer & Trustee by St. Paul's School.
He also served on the board at GPC Biotech AG.
He received his undergraduate degree from Harvard College and an MBA from Harvard Business School.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
10/09/2026 400.156 ( 0,36 % ) 14 M $ 31/08/2026

Cargos activos de Jim Frates

EmpresasCargoInicio
AMYLYX PHARMACEUTICALS, INC. Director Financiero/CFO 01/01/2021
Director/Miembro de la Junta -

Antiguos cargos conocidos de Jim Frates.

EmpresasCargoFin
SAGE THERAPEUTICS, INC. Director/Miembro de la Junta 31/07/2025
ALKERMES PLC Director Financiero/CFO 11/01/2021
Director/Miembro de la Junta 01/06/2009
Director/Miembro de la Junta 01/01/2009
Corporate Officer/Principal 01/06/1998
Ver el detalle de la experiencia de Jim Frates.

Formación de Jim Frates.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

76

Relaciones de 1er grado

11

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas11

Commercial Services

Finance

Commercial Services

Commercial Services

Consumer Services

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology